Advertisement

Topics

ERYtech Pharma Company Profile

07:07 EDT 26th September 2017 | BioPortfolio

ERYtech Pharma is a specialty pharma company developing innovative therapeutic solutions based on its proprietary technology and expertise in the physiological properties of erythrocytes. The company addresses serious pathologies, orphan indications or sub-populations of patients, particularly in the fields of haematology, cancer and metabolic diseases.


News Articles [2331 Associated News Articles listed on BioPortfolio]

Erytech Pharma privately raises €70.5mm

Erytech Pharma SA raised €70.5mm ($84.5mm) through the private sale of 3mm new ordinary shares to undisclosed investors. Funds will support pipeline development activity, including an upcoming Phase...

ERYTECH Pharma: Information related to total number of voting rights and shares composing the share capital -May 31st, 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY): Listing market: Euronext Paris from EuronextMarket segment ....

ERYTECH Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital -July 31st, 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY): Listing market: Euronext Paris from EuronextMarket segment ....

ERYTECH präsentiert auf der Morgan Stanley Global Healthcare Conference

ERYTECH Pharma (Paris:ERYP) (ADR: EYRYY) (Euronext Paris ERYP), ein Biopharma-Unternehmen, das sich mit der klinischen Phase der Entwicklung innovativer Therapien befasst, bei denen Wirkstoffe in ...

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research coll...

ERYTECH meldet Kooperation mit der Queen's University zur Weiterentwicklung des Produktkandidaten für seltene Stoffwechselerkrankungen

ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY) (Euronext Paris ERYP), ein französisches Biopharma-Unternehmen, das sich mit der klinischen Phase der Entwicklung innovativer Therapien für seltene Krebsfor.....

ERYTECH présentera de nouvelles données précliniques à l’occasion du 13ème congrès international des erreurs innées du métabolisme (ICIEM)

Friday, September 1st 2017 at 6:00am UTC Deux abstracts d’ERYTECH acceptés pour la présentation de posters Les présentations mettent en exergue les données précliniques de l’utilisation de la...

Erytech and Queen’s University collaborate for arginase-1 deficiency treatment

French biopharmaceutical company Erytech Pharma has entered a research collaboration with Queen’s University in Canada to advance the preclinical development of its eryminase programme, particularly...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [32 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

AI-powered drug discovery captures pharma interest.

Clinical Trials Series - Large Pharma.

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [717 Associated Companies listed on BioPortfolio]

ERYtech Pharma

ERYtech Pharma is a specialty pharma company developing innovative therapeutic solutions based on its proprietary technology and expertise in the physiological properties of eryth...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

More Information about "ERYtech Pharma" on BioPortfolio

We have published hundreds of ERYtech Pharma news stories on BioPortfolio along with dozens of ERYtech Pharma Clinical Trials and PubMed Articles about ERYtech Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ERYtech Pharma Companies in our database. You can also find out about relevant ERYtech Pharma Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record